Professional Documents
Culture Documents
1
Disclaimer & Risk Warning
The information contained herein does not purport to be all-inclusive or to contain all of the information a prospective or existing investor may desire. In all cases,
interested parties should conduct their own investigation and analysis of Quintessentially Ventures Limited and the data set forth in this document. No representation, or
warranty, express or implied, is or will be given by the Company as to the accuracy or completeness of the document or the information or opinions contained therein. This
document is communicated by the Company to its qualifying members on the basis of such recipient's status as a professional investor in accordance with FCA
regulations.
This presentation contains forward-looking statements regarding the plans and objectives of the Company with respect to its business. These forward-looking statements
are based on current expectations that involve numerous risks and uncertainties. The Company's plans and objectives are based on numerous assumptions that involve
judgments with respect to factors beyond the control of the Company. Although the Company believes that the assumptions underlying the forward-looking statements are
reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance that the forward-looking statements included in this presentation will
prove to be accurate.
Investing in early stage businesses involves risks, including illiquidity (the inability to sell assets quickly or without substantial loss in value), lack of dividends, loss of
investment and dilution, and it should be done only as part of a diversified portfolio. There is no secondary market available meaning that these securities are illiquid. As a
result, you may lose all of your capital. This presentation is targeted at investors who are sufficiently sophisticated to understand these risks and make their own
investment decisions. If any potential investors are in doubt regarding the contents of this document, they must consult their own professional financial advisors. The tax
treatment of this business depends on the individual circumstances of each investor and may be subject to change. Past performance is not indicative of future
performance.
Enterprise Investment Scheme (“EIS”) Investors should be aware that the availability of EIS relief is dependent on investors’ own personal circumstances, as well as those
of the Company, and are subject to change. There can be no guarantee that any particular tax relief will be available at any relevant time or that the Company will continue
to be a qualifying investment. There is no guarantee that EIS or other relevant status can be maintained throughout the life of your investment. Non-compliance may result
in the loss or partial clawback of any tax reliefs claimed together with potential interest penalties. Investors should seek their own independent professional advice on their
particular tax situation and the application of such tax reliefs prior to making any investment.
QVentures is a trading name of Quintessentially Ventures Limited, which is an Appointed Representative of Brooklands Fund Management Limited which is authorised and
regulated by the Financial Conduct Authority (FRN 757575). Qventures is not registered with the Securities and Exchange Commission.
2
QVentures is a Venture Capital firm which supports best in
class entreprepreneurs with access to funding, either
directly through our fund or through our vetted pool of high
calibre investors.
4
We look for disruptive companies with proven product
market fit, set scale from Pre-Seed to Series C
A Selection of our Portfolio Companies:
We invest broadly
Manufacturing
across the UK’s tech
Autonomous
EdTech
FinTech
Series A CLN Series A CLN Series A sectors.
£14m Raised £2.5m Raised £1.5m Raised
Atomico Led Round IQ Capital Led Round DMG Led Round
Sectors we have
invested include:
Fintech NeoBank
Fintech, Healthcare
and EdTech.
HealthTech
Series C Series C Series E
FinTech
£3m Raised £2m Raised £2m Raised
Investec Led Round Tencent Led Round Y Combinator Led Round
7 Year Track Record
Electric Vehicle
+ 115 Startups
Retail Tech
Charging
AdTech
4X Return in 5 Years Series B See full portfolio at
17X Return in 3 £4.3m Raised by QV
£100m acquisition by www.qventures.co
Years Impulse VC Led Round
EDF Energy
Acquired by Emplifi
*Companies that are changing industries by bringing efficiencies and new ways of consumption and could come to dominate these sectors 5
Team of 12 Investment Professionals
With over 30 years of Venture Capital Experience to support you and advise you on Venture Capital Investments.
During the pandemic we raised capital "I'd happily recommend QVentures. Their approach was professional
for 77% of the businesses we took from the outset, their strategy thoughtful and realistic and they were
able to connect us to the right investors at the right time."
out to the market.
- Michael Wallace, Founder, Oxford Medical Simulations
7
A Few Examples
Series A
CLN* 20% Discount £80m Cap.
£20m Round (£8.5m raised by QV)
Autonomous Manufacturing
CloudNC has developed world-first AI software that automates and removes all skilled human
roles in Precision Factories ($168B market), while also multiplying the yield of the machinery.
The result is the potential for a >50x increase in gross profit per machine, in a rapidly scalable
and highly defensible full-stack business model.
Noteworthy Points
Current Investors
Lead Investor
8
A Few Examples
Series C
Equity, Pre-Money Valuation £60m
£40m Round (£2m raised by QV)
Congenica is
Congenica’s world-leading software analyses genomic data 20x faster than industry averages building a future
HealthTech B2B SaaS
and provides a 30% higher analytical yield while reducing costs by up to 95%.
- £2m Revenue in 2019 and exclusive provider to NHS Genomic Medicine Service.
- 350 Million Rare Disease sufferers, 50% are children, 30% don't see the age of 5.
- The leading solution for hard to diagnose rare and inherited diseases founded and
developed by clinical leaders from the Sanger Institute and UK NHS Great Ormond St.
Hospital with planned market expansion post series C.
- Round co-led by Tencent and Legal & General alongside existing investors CIC,
Parkwalk, Downing and new participants Xeraya, Puhua and IDO.
Current Investors
9
A Few Examples
Series A
Equity, Pre-Money Valuation £32.8m
£6m Round (£2m raised by QV)
EdTech B2B SaaS
Kortext is the UK’s leading B2B2C Digital Learning Platform that aims to solve a key problem in
Higher Education (HE) - discovery and access to over 1m key digital textbooks from over 1,450
publishers in one easy to use content and learning platform.
Academics then get content usage analytics returned to them measuring student engagement.
With all students now having to study remotely and away from campus and library this is a key
way of universities continuing to reach out to their students and ensure they continue to be The UK’s leading digital
engaged with their studies and leading up to year-end exams.
textbook platform
Noteworthy Points
- £7.2m revenue forecasted for 2019 / 20, year-end in June, with £14m projected for
- 2020/21.
120+ UK universities use Kortext Platform for accessing digital textbooks and
other learning materials, multi-year contracts that aim to move from modules to the
- whole institution.
Plans for international expansion in the Middle East, ASEAN and Australia/NZ,
including government partnerships (Egypt) and potential launch support from dmg's
(Daily Mail Group) portfolio company, Hobsons, to enter the US market in due course.
Current Investors
Lead Investor
10
A Few Examples
Series A
CLN* 25% Discount
£10m Round (£2m raised by QV)
FinTech
“We ran an internal exercise to size building what you [BMLL] have built, and the full build is
close to $100m, then you add the annual running costs” - CIO Global Investment Bank
Noteworthy Points
- $120k MRR, 85 % Gross Margin and 320 % ARR growth over the last 18 months
- Clients include Goldman Sachs, LSE, Citi, Credit Suisse, Six Swiss & Schroders
- Cambridge University spinout and Bank of England FinTech Accelerator graduate
- Round led by IQ Capital (Bloomsbury AI, Grapeshot, ThoughtMachine, Privitar,
Funderbeam)
Current Investors
Lead Investor
11
Our Services Each offering provides founders with
access to a Pitch event with 30
targeted investors (~£6Bn in assets).
We offer three core types of support:
We support founders who have We work with businesses who The QVentures Pre-Seed Fund
secured a lead investor to raise would like to raise larger sums of invests in early-stage technology
additional capital into their round. money over the course of 3-6 companies based in the United
Through providing a managed months. This is typically with Kingdom at seed or earlier stage.
service and access to an untapped Series A+ companies who are The fund invests directly into
pool of capital we enable them to either looking for support to 10-20 high growth technology
close out their total round secure a lead investor or later businesses annually and focuses
quicker with high impact stage deals who are looking for on Marketplace, Enterprise SaaS,
investors and less demand on sizable top ups to their rounds. and Consumer Tech companies.
their business.
12
We introduce relevant, sophisticated and credible investors
153 Family Offices | 254 Institutional Investors | 667 UHWNI
Total Investable Assets of £61Bn* Average Investable Assets £461m* Investing Tickets Size of £250k - £10m
Italian Single FO English Single FO Indian Single FO UAE Single FO
£750m Investable Assets £1.5Bn Investable Assets £800m Investable Assets £1.7Bn Investable Assets
Source: Financial Services / Paper Industry Source: Retail / Real Estate Source: Commodities Source: Industrial / Automotive
Sophisticated Patient Capital. Bringing network, business interests and knowhow to the table.
No fund economics and timelines to deliver returns - just friendly capital partnering with you and your existing shareholders for the long term
* Note these are based on information provided by the clients and are an approximations as asset values can increase or decrease 13
We introduce relevant, sophisticated and credible investors
153 Family Offices | 254 Institutional Investors | 667 UHWNI
Total Investable Assets of £50.8Bn* Average Fund Size £200m* Investing Tickets Size of £500k - £20m
113 54 83
European Venture Funds Corporate VC Funds EIS & VCT Funds
Our Relationships can help get in front of Institutional Investors in an efficient process.
Save time knocking on doors and using your current cap table to be introduced to investors.
We will introduce you to relevant Fund Managers actively looking to deploy capital in your industry.
* Note these are based on information provided by the clients and are an approximations as asset values can increase or decrease
14
We introduce relevant, sophisticated and credible investors
153 Family Offices | 254 Institutional Investors | 667 UHWNI
Total Investable Assets of £34Bn* Average Investable Assets £51m* Investing Tickets Size of £100k - £5m
Exited Asset Management Entrepreneur CEO of Tier 1 Bank & Inheritance Real Estate Entrepreneur Exited Tech Entrepreneur
£231m Investable Assets £87m Investable Assets £171m Investable Assets £131m Investable Assets
All investors we introduce are vetted to reduce the risk of challenging or troublesome investors
* Note these are based on information provided by the clients and are an approximations as asset values can increase or decrease 15
Value-Add Investors
Strategic Support Board Positions
17
Get in Touch
18